537 related articles for article (PubMed ID: 30549039)
21. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
22. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
Wang C; Tan S; Liu WR; Lei Q; Qiao W; Wu Y; Liu X; Cheng W; Wei YQ; Peng Y; Li W
Mol Cancer; 2019 Sep; 18(1):134. PubMed ID: 31484581
[TBL] [Abstract][Full Text] [Related]
23. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
Li L; Liu YD; Zhan YT; Zhu YH; Li Y; Xie D; Guan XY
Thorac Cancer; 2018 Jul; 9(7):775-784. PubMed ID: 29722145
[TBL] [Abstract][Full Text] [Related]
24. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
Huang G; Zhang J; Gong L; Huang Y; Liu D
BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
[TBL] [Abstract][Full Text] [Related]
25. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
[TBL] [Abstract][Full Text] [Related]
26. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.
Samad A; Jafar T; Rafi JH
Genomics; 2020 Nov; 112(6):4912-4923. PubMed ID: 32916258
[TBL] [Abstract][Full Text] [Related]
27. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
28. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
29. High Expression of
Zhao T; Qian K; Zhang Y
J Comput Biol; 2020 Jun; 27(6):948-957. PubMed ID: 31553229
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
31. Smoking is Associated with Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Progression through Inducing Distinguishing lncRNA Alterations in Different Genders.
Liu B; Liu Y; Zou J; Zou M; Cheng Z
Anticancer Agents Med Chem; 2022; 22(8):1541-1550. PubMed ID: 34315392
[TBL] [Abstract][Full Text] [Related]
32. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Yin D; Zhang Y; Li H; Cheng L
Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
[TBL] [Abstract][Full Text] [Related]
33. Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma.
Song Y; Chen D; Zhang X; Luo Y; Li S
Thorac Cancer; 2019 May; 10(5):1220-1228. PubMed ID: 30993904
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
35. Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape.
Xia W; Mao W; Chen R; Lu R; Liu F; He Y; Wang S; Li X; Zheng M
Med Sci Monit; 2019 Nov; 25():8764-8776. PubMed ID: 31746315
[TBL] [Abstract][Full Text] [Related]
36. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
37. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Li Q; Hou J; Hu Z; Gu B; Shi Y
Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
[TBL] [Abstract][Full Text] [Related]
38. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods.
Chen JW; Dhahbi J
Sci Rep; 2021 Jun; 11(1):13323. PubMed ID: 34172784
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Zengin T; Önal-Süzek T
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117
[TBL] [Abstract][Full Text] [Related]
40. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
